Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Graessmann

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
FEBS Letters|June 3, 1991
After microinjection hemimethylated DNA is converted into symmetrically methylated DNA before DNA replicationG Sandberg, E Guhl, M Graessmann, et al.
Journal of Virology|June 1, 1987
Cellular mutation mediates T-antigen-positive revertant cells resistant to simian virus 40 transformation but not to retransformation by polyomavirus and adenovirus type 2M Bauer, E Guhl, M Graessmann, et al.
FEBS Letters|September 30, 1996
SV40 T1-mRNA trans-splicing and translation requires that the in vitro synthesized cRNA is capped before microinjectionM Graessmann, J Eul, B Berg, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1983
Complete DNA methylation does not prevent polyoma and simian virus 40 virus early gene expressionM Graessmann, A Graessmann, H Wagner, et al.
Journal of Virology|March 1, 1980
Simian virus 40 small-t protein is required for loss of actin cable networks in rat cellsA Graessmann, M Graessmann, R Tjian, et al.
Oncogene|July 1, 1993
Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid geneY J Tzeng, E Guhl, M Graessmann, et al.
Journal of Virology|December 1, 1979
Retransformation of a simian virus 40 revertant cell line, which is resistant to viral and DNA infections, by microinjection of viral DNAA Graessmann, M Graessmann, W C Topp, et al.
Oncogene|December 13, 2006
Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteopontin, inhibiting apoptosis downstream of caspase-3M Graessmann, B Berg, B Fuchs, et al.
Nucleic Acids Research|August 25, 1989
Helper activity for gene expression, a novel function of the SV40 enhancerM Graessmann, J Menne, M Liebler, et al.
Oncogene|October 1, 1991
Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cellsW Deppert, M Kurth, M Graessmann, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
FEBS Letters|June 3, 1991
After microinjection hemimethylated DNA is converted into symmetrically methylated DNA before DNA replicationG Sandberg, E Guhl, M Graessmann, et al.
Journal of Virology|June 1, 1987
Cellular mutation mediates T-antigen-positive revertant cells resistant to simian virus 40 transformation but not to retransformation by polyomavirus and adenovirus type 2M Bauer, E Guhl, M Graessmann, et al.
FEBS Letters|September 30, 1996
SV40 T1-mRNA trans-splicing and translation requires that the in vitro synthesized cRNA is capped before microinjectionM Graessmann, J Eul, B Berg, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1983
Complete DNA methylation does not prevent polyoma and simian virus 40 virus early gene expressionM Graessmann, A Graessmann, H Wagner, et al.
Journal of Virology|March 1, 1980
Simian virus 40 small-t protein is required for loss of actin cable networks in rat cellsA Graessmann, M Graessmann, R Tjian, et al.
Oncogene|July 1, 1993
Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid geneY J Tzeng, E Guhl, M Graessmann, et al.
Journal of Virology|December 1, 1979
Retransformation of a simian virus 40 revertant cell line, which is resistant to viral and DNA infections, by microinjection of viral DNAA Graessmann, M Graessmann, W C Topp, et al.
Oncogene|December 13, 2006
Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteopontin, inhibiting apoptosis downstream of caspase-3M Graessmann, B Berg, B Fuchs, et al.
Nucleic Acids Research|August 25, 1989
Helper activity for gene expression, a novel function of the SV40 enhancerM Graessmann, J Menne, M Liebler, et al.
Oncogene|October 1, 1991
Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cellsW Deppert, M Kurth, M Graessmann, et al.
Pageof 4